PPIA and viral infectious disease: For another, since CsA has also been used in inflammatory diseases, one future direction is to find nonimmunosuppressive CsA derivatives or novel agents to inhibit the role of cyclophilin A in inflammation but not affect host immunity during viral infection control or cancer treatment.